Forum Financial Management LP Increases Stake in Johnson & Johnson (NYSE:JNJ) by 11.2%

Are you interested in investing in Johnson & Johnson (NYSE:JNJ)? Well, you’re not alone! Forum Financial Management LP recently raised its position in JNJ by 11.2% in the 1st quarter, showing confidence in the company’s potential. But what’s the buzz all about?

First off, let’s talk numbers. JNJ stock is currently down by 0.5%, opening at $154.69 on Friday. With a market cap of $372.29 billion and a P/E ratio of 9.64, Johnson & Johnson is a major player in the healthcare industry. The company recently reported quarterly earnings that beat analysts’ estimates, showing a strong performance in a competitive market.

But what about dividends? Johnson & Johnson also announced a quarterly dividend of $1.24 per share, with a dividend yield of 3.21%. This is great news for investors looking for steady returns on their investment.

And what do Wall Street analysts have to say? Well, opinions are mixed, with some analysts giving JNJ a “buy” rating and others a “neutral” rating. However, the consensus seems to be leaning towards a “Moderate Buy” rating, with an average price target of $175.00.

So, if you’re considering investing in Johnson & Johnson, now might be a good time to do some research and see if it aligns with your investment goals. And if you want to stay updated on the latest news and ratings for JNJ, be sure to sign up for MarketBeat.com’s FREE daily email newsletter.

In conclusion, Johnson & Johnson is a solid company with a strong track record in the healthcare industry. With positive earnings, dividends, and analyst ratings, it’s definitely worth keeping an eye on for potential investment opportunities. Stay informed, stay engaged, and happy investing!